Compare PDX & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDX | ACHC |
|---|---|---|
| Founded | 2019 | 2005 |
| Country | NY | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 904.4M | 1.1B |
| IPO Year | N/A | 2011 |
| Metric | PDX | ACHC |
|---|---|---|
| Price | $20.60 | $25.32 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $21.64 |
| AVG Volume (30 Days) | 126.4K | ★ 3.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.95% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,312,769,000.00 |
| Revenue This Year | N/A | $5.23 |
| Revenue Next Year | N/A | $5.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.04 |
| 52 Week Low | $18.47 | $11.43 |
| 52 Week High | $25.25 | $31.43 |
| Indicator | PDX | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 62.02 | 85.60 |
| Support Level | $19.90 | $20.88 |
| Resistance Level | $22.15 | $27.50 |
| Average True Range (ATR) | 0.28 | 1.21 |
| MACD | 0.05 | 0.72 |
| Stochastic Oscillator | 86.52 | 97.06 |
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.